We have changed our name from Cure Our Ovarian Cancer to the Ovarian Cancer Foundation NZ » Read More

Formerly Cure Our Ovarian Cancer > Read more

Research Updates

LGSOC Webinar with Dr Amanda Fader

LGSOC Webinar with Dr Amanda Fader

September 21, 2025

Over $400,000 awarded for LGSOC research in the United States

Over $400,000 awarded for LGSOC research in the United States

July 14, 2025

Dr Gershenson looking into the camera

LGSOC Webinar With Dr Gershenson

September 12, 2024

Scientist with dark hair wearing a white lab coat looking directly at the camera

Study highlights the benefit of surgery in low-grade serous ovarian cancer

September 4, 2024

Dr Rob Hollis looking into a microscope

UK Drug Screening Identifies Potential New Low-Grade Serous Ovarian Cancer Treatments

April 29, 2024

Decorative image of pill bottle

Ramp 301 Clinical Trial Opens

April 27, 2024

a group of people wearing facemasks in a lab

LGSOC Initiative Funded Endocrine Study Published In British Journal Of Cancer

April 15, 2024

A person setting up a high-tech microscope

Low-Grade Serous Ovarian Cancer: Expert Consensus Report On The State Of The Science

September 5, 2023

five old fashioned microscopes laid out on an orange backgroud

Ribociclib And Letrozole In Recurrent Low-Grade Serous Ovarian Cancer: Phase II Clinical Trial Results

August 16, 2023

share your perspective

Survey Opportunity August 2023

August 2, 2023

Patient Stories Needed To Share With The FDA

July 26, 2023

Dr Sandro Pignata

Research Update: Bevacizumab Use In Advanced Ovarian Cancer

July 8, 2023

a stethoscope and pills on a bench

Updated Results From Phase 2 Low-Grade Serous Ovarian Cancer Clinical Trial

January 27, 2023

Dr Gershenson looking in to the camera

New Study Suggests Low-Grade Serous Ovarian Cancer Recurrence Rates Are Decreasing With New Treatments

December 10, 2022

Unprecedented response rates in LGSOC trial

Unprecedented Response Rate In Neoadjuvent Trial For Low-Grade Serous Ovarian Cancer

June 7, 2022

Updates on LGSOC research and treatment

Updates In Low-Grade Serous Ovarian Cancer Treatment And Research Nov 2021

November 16, 2021

Dr Banjerjee speaking

Dr Banerjee Gives An Update On Phase I/II Frame Trial For RAF/MEK/FAK Inhibitor

September 22, 2021

sharing the story behind the research

Interview With UK Researcher and Oncologist Professor Gourley

August 20, 2021

Dr Wong in his lab wearing a facemask

Research Grant Awarded To MD Anderson Cancer Center

August 19, 2021

Dr Banerjee smiling into the camera

Verastem Oncology Investigates New LGSOC Treatment

December 3, 2020

two women on a golf course

Impact Of Aromatase Inhibitor Therapy On Women With Gynaecological Cancers

December 2, 2020

Ursula looking into the camera

Dana-Farber/Harvard Cancer Center Awarded National Cancer Institute Grant To Study New Combination Therapy In LGSC

November 15, 2020

Dr Chealsey sitting in his lab

Australian Low-Grade Serous Ovarian Cancer Researcher Awarded Federal Grant

July 19, 2020

Stephanie speaking

Is Chemotherapy Necessary In Newly Diagnosed Low-Grade Serous Ovarian Cancer?

July 8, 2020

Dr Rachel Grisham smiling in to the camera

Binimetinib In Low-Grade Serous Carcinoma

December 27, 2019

Ida Madsen looking onto a microscope

Visit to Sydney Low-Grade Serous Research Laboratory

October 25, 2019

Study Shows Trametinib Improves Outcomes for Women with Low-Grade Serous Carcinoma of the Ovary/Peritoneum on NRG Oncology Trial

September 30, 2019

Facade of the University of Miami Health Centre Building

Inaugural Low-Grade Serous Ovarian Cancer Symposium

February 10, 2019